Core Scientific, Inc.
CORZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $5 | $2 | $4 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $6 | $6 | $3 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.1% | -1.1% | -16.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 4.7% | 6.4% | 10.3% | 5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -157.2% | -0.8% | -25.4% | -247.4% |
| Net Income | -$0 | -$1 | $1 | -$0 |
| % Margin | -180.8% | -1,191.4% | 730.2% | -279.7% |
| EPS Diluted | -0.46 | -0.042 | 1.25 | -0.6 |
| % Growth | -1,003.1% | -103.3% | 308.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |